Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,964 | -123,145 | -85,361 | -54,616 | -27,739 |
| Depreciation Amortization | 15,948 | 11,790 | 329 | 241 | 138 |
| Income taxes - deferred | 20 | 90 | 67 | 45 | 22 |
| Accounts receivable | -669 | -2,822 | -1,794 | -604 | -449 |
| Other Working Capital | -8,032 | -35,577 | -30,853 | -28,091 | -12,018 |
| Other Operating Activity | 5,969 | 22,207 | 14,744 | 8,979 | 4,770 |
| Operating Cash Flow | $-27,728 | $-127,457 | $-102,868 | $-74,046 | $-35,276 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 11,508 | 11,508 |
| PPE Investments | -2,037 | -2,777 | 11,076 | -164 | -61 |
| Sale Of Investment | N/A | 11,508 | N/A | N/A | N/A |
| Investing Cash Flow | $-2,037 | $8,731 | $11,076 | $11,344 | $11,447 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 125,000 | N/A | N/A | N/A |
| Common Stock Issued | 6 | 119,747 | 119,731 | 119,722 | 118,381 |
| Common Stock Repurchased | N/A | -15 | -15 | -15 | N/A |
| Financing Cash Flow | $6 | $244,732 | $119,716 | $119,707 | $118,381 |
| Beginning Cash Position | 200,290 | 74,284 | 74,284 | 74,284 | 74,284 |
| End Cash Position | 170,531 | 200,290 | 102,208 | 131,289 | 168,836 |
| Net Cash Flow | $-29,759 | $126,006 | $27,924 | $57,005 | $94,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,728 | -127,457 | -102,868 | -74,046 | -35,276 |
| Capital Expenditure | -2,037 | -2,777 | -432 | -164 | -61 |
| Free Cash Flow | -29,765 | -130,234 | -103,300 | -74,210 | -35,337 |